FDA: Don’t Use Chinese Infant Formula
Sept. 12, 2008 -- The FDA is warning parents and caregivers not to feed infant formula made in China to infants because of possible contamination with melamine, a chemical linked to tainted animal feed last year.
Infant formulas made in the U.S. are safe to use.
In China, one baby has died and others have developed kidney problems linked to melamine in Chinese infant formula, according to news reports.
Melamine artificially makes milk appear to have more protein; it can cause kidney diseases such as those seen in the Chinese infants, the FDA notes.
Infant formulas made in China shouldn't be on store shelves, regardless of melamine. The FDA requires all infant formula makers to register with the FDA and to meet certain standards; no Chinese companies have met those requirements.
The FDA issued the warning just in case any specialty markets serving the Asian community sell any Chinese infant formulas; the FDA is looking into that.
The following manufacturers have met the FDA's requirements for marketing infant formulas in the U.S.: Abbott Nutritionals, Mead Johnson Nutritionals, Nestle USA, PBM Nutritionals, Solus Products LLC, and SHS/Nutricia of Liverpool, England. Their products are safe and are not imported from China or made from materials from China, according to the FDA.
Important Safety Information
Vimpat (lacosamide) is a medicine that is used with other medicines to treat partial onset seizures in patients 17 years of age and older with epilepsy. Vimpat is generally well-tolerated, but may not be for everyone. Ask your doctor if Vimpat is right for you. Antiepileptic drugs, including Vimpat, may cause suicidal thoughts or actions in a very small number of people, about 1 in 500. Call your healthcare provider right away if you have new or worsening symptoms of depression, any unusual changes in mood or behavior, or suicidal thoughts, behavior, or thoughts about self harm that you have never had before or may be worse than before. Please see additional patient information in the Medication Guide at the end of the full prescribing information. This information does not take the place of talking with your healthcare provider about your condition or your treatment. Please see additional Patient Safety Information


